XML 58 R45.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Related Party Transactions - Additional Information (Detail) |  |  |  |  |  |  |  | 9 Months Ended | 12 Months Ended | 16 Months Ended | 20 Months Ended |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jul. 24, 2017 USD ($) $ / shares shares | Jul. 20, 2017 USD ($) shares | Jul. 19, 2017 USD ($) shares | Jul. 18, 2017 USD ($) $ / shares shares | Mar. 07, 2017 USD ($) | Sep. 30, 2015 USD ($) $ / shares shares | May 18, 2015 USD ($) | Sep. 30, 2018 USD ($) $ / shares | Sep. 30, 2016 USD ($) | Dec. 31, 2017 USD ($) $ / shares | Dec. 31, 2016 USD ($) NotesPayable | Dec. 31, 2016 USD ($) | Dec. 31, 2016 USD ($) | May 23, 2018 $ / shares | Jul. 31, 2017 USD ($)
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value | $ / shares |  |  |  |  |  |  |  | $ 0.001 |  | $ 0.001 |  |  |  | $ 0.001 |
Ricanto, Ltd [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consulting fees incurred, related parties |  |  |  |  |  |  |  |  | $ 100,000 | $ 0 |  |  |  |  |
Related party consulting agreement, date of termination |  |  |  |  |  |  |  | Aug. 01, 2017 |  |  |  |  |  |  |
Accounts payable, related parties |  |  |  | $ 600,000 |  |  |  | $ 0 |  |  | $ 600,000 | $ 600,000 | $ 600,000 |  |
Shares issued to related party for services | shares |  |  |  | 475 |  |  |  |  |  |  |  |  |  |  |
Shares issued to related party, par value | $ / shares |  |  |  | $ 0.01 |  |  |  |  |  |  |  |  |  |  |
Ricanto, Ltd [Member] | OncoGenex Pharmaceuticals, Inc [Member] | Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares post-conversion | shares |  |  |  | 17,067 |  |  |  |  |  |  |  |  |  |  |
Chief Executive Officer [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable, related parties |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |
Notes payable, related parties |  |  |  |  |  |  |  |  |  |  | $ 200,000 | 200,000 | 200,000 |  |
Number of notes payable | NotesPayable |  |  |  |  |  |  |  |  |  |  | 2 |  |  |  |
Notes payable, rate of interest |  |  |  |  |  |  |  |  |  |  | 3.50% |  |  |  |
Notes payable repayment period |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |
Outstanding principal, included in shareholder loans |  |  |  |  |  |  |  |  |  |  | $ 200,000 | 200,000 | 200,000 |  |
Accrued interest owed to related party |  |  |  |  |  |  |  | 0 |  |  | 3,000 | 3,000 | 3,000 |  |
Salary paid |  |  |  |  |  |  |  |  |  |  |  |  | 0 |  |
Chief Executive Officer [Member] | Accrued Compensation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salary paid |  |  | $ 400,000 |  |  |  |  |  |  |  |  |  |  |  |
Accrued salaries |  |  |  |  |  |  |  |  |  |  | 700,000 | 700,000 | 700,000 |  |
Accrued salaries, common stock shares issued | shares |  |  | 238 |  |  |  |  |  |  |  |  |  |  |  |
Percentage of common stock issued in settlement of accrued salaries |  |  | 50.00% |  |  |  |  |  |  |  |  |  |  |  |
Percentage of cash payment in settlement of accrued salaries |  |  | 50.00% |  |  |  |  |  |  |  |  |  |  |  |
Chief Executive Officer [Member] | Convertible Notes Payable [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued to related party, par value | $ / shares | $ 0.01 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt conversion, converted instrument, amount | $ 200,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt conversion, converted instrument, shares issued | shares | 146 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Chief Executive Officer [Member] | OncoGenex Pharmaceuticals, Inc [Member] | Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares post-conversion | shares | 5,246 |  | 8,551 |  |  |  |  |  |  |  |  |  |  |  |
Lender |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable, related parties |  |  |  |  |  |  |  | 0 |  |  | 700,000 | 700,000 | 700,000 |  |
Notes payable, related parties |  |  |  |  | $ 20,000 |  |  |  |  |  |  |  |  |  |
Notes payable, rate of interest |  |  |  |  | 3.50% |  |  |  |  |  |  |  |  |  |
Notes payable repayment period |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |
Accrued interest owed to related party |  |  |  |  |  |  |  | 0 |  |  | 35,000 | 35,000 | 35,000 |  |
Debt conversion, converted instrument, amount | $ 800,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt conversion, converted instrument, shares issued | shares | 586 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value | $ / shares | $ 0.01 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Lender | Convertible Promissory Note [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes payable, related parties |  |  |  |  |  |  | $ 2,700,000 |  |  |  |  |  |  |  |
Notes payable, rate of interest |  |  |  |  |  |  | 3.50% |  |  |  |  |  |  |  |
Debt conversion, converted instrument, amount |  |  |  |  |  | $ 2,000,000 |  |  |  |  |  |  |  |  |
Debt conversion, converted instrument, shares issued | shares |  |  |  |  |  | 4,500 |  |  |  |  |  |  |  |  |
Common stock, par value | $ / shares |  |  |  |  |  | $ 0.01 |  |  |  |  |  |  |  |  |
Lender | OncoGenex Pharmaceuticals, Inc [Member] | Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares post-conversion | shares | 182,743 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Chief Financial Officer [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable, related parties |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |
Accrued interest owed to related party |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |
Salary paid |  |  |  |  |  |  |  |  |  |  |  | 0 |  |  |
Chief Financial Officer [Member] | Accrued Compensation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salary paid |  | $ 200,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Accrued salaries |  |  |  |  |  |  |  |  |  |  | $ 300,000 | $ 300,000 | $ 300,000 |  |
Accrued salaries, common stock shares issued | shares |  | 127 |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of common stock issued in settlement of accrued salaries |  | 50.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of cash payment in settlement of accrued salaries |  | 50.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Chief Financial Officer [Member] | OncoGenex Pharmaceuticals, Inc [Member] | Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares post-conversion | shares |  | 4,563 |  |  |  |  |  |  |  |  |  |  |  |  |
Michelle Griffin [Member] | OncoGenex Pharmaceuticals, Inc [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Termination fee payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 600,000
Michelle Griffin [Member] | OncoGenex Pharmaceuticals, Inc [Member] | Accrued Liabilities Other [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Party Transaction [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable, related parties |  |  |  |  |  |  |  | $ 0 |  |  |  |  |  |  |

X
- Definition Common stock issued in settlement of accrued salaries shares. + References No definition available. + Details
Name: | achv_CommonStockIssuedInSettlementOfAccruedSalariesShares
Namespace Prefix: | achv_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Notes payable repayment period. + References No definition available. + Details
Name: | achv_NotesPayableRepaymentPeriod
Namespace Prefix: | achv_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of notes payable. + References No definition available. + Details
Name: | achv_NumberOfNotesPayable
Namespace Prefix: | achv_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of cash payment in settlement of accrued salaries. + References No definition available. + Details
Name: | achv_PercentageOfCashPaymentInSettlementOfAccruedSalaries
Namespace Prefix: | achv_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of common stock issued in settlement of accrued salaries. + References No definition available. + Details
Name: | achv_PercentageOfCommonStockIssuedInSettlementOfAccruedSalaries
Namespace Prefix: | achv_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Termination fee payable to related party. + References No definition available. + Details
Name: | achv_TerminationFeePayableToRelatedParty
Namespace Prefix: | achv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6911-107765 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765 + Details
Name: | us-gaap_AccruedSalariesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586 + Details
Name: | us-gaap_DebtConversionConvertedInstrumentAmount1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586 + Details
Name: | us-gaap_DebtConversionConvertedInstrumentSharesIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(12)) -URI http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(17)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(k)(1)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)(a)(5)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_DueToOfficersOrStockholdersCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(k)(1)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_DueToRelatedPartiesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e7018-107765 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_InterestPayableCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(k)(1)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)(5)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_NotesPayableRelatedPartiesClassifiedCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Payments of cash to employees, including wages and salaries, during the current period. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 17 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3367-108585 + Details
Name: | us-gaap_PaymentsToEmployees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Date of maturity or expiration of arrangements with a related party (for example, but not limited to, leasing and debt arrangements between related parties), in CCYY-MM-DD format. + References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 + Details
Name: | us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties. + References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of stock issued during the period pursuant to acquisitions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesAcquisitions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=achv_RicantoLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=achv_OncoGenexPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=achv_AccruedCompensationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=achv_LenderMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ShortTermDebtTypeAxis=achv_ConvertiblePromissoryNoteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefFinancialOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=achv_AccruedLiabilitiesOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |